Blood thinner combo shows promise for leg artery disease
NCT ID NCT05009862
First seen Jan 04, 2026 · Last updated Jun 08, 2026 · Updated 26 times
Summary
This study looked at how the blood thinner rivaroxaban, taken with aspirin, affects blood vessel health and clotting in 60 people with peripheral artery disease (PAD). Participants received low-dose rivaroxaban plus aspirin or aspirin plus placebo. The goal was to see if the combination improves blood vessel function and reduces platelet activation. The study is complete and helps understand how this treatment works for PAD symptoms.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PERIPHERAL ARTERIAL DISEASE are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Vanderbilt University Medical Center
Nashville, Tennessee, 37232, United States
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.